NO171065C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater

Info

Publication number
NO171065C
NO171065C NO882233A NO882233A NO171065C NO 171065 C NO171065 C NO 171065C NO 882233 A NO882233 A NO 882233A NO 882233 A NO882233 A NO 882233A NO 171065 C NO171065 C NO 171065C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
pyrimidine derivatives
analogy procedure
active pyrimidine
Prior art date
Application number
NO882233A
Other languages
English (en)
Norwegian (no)
Other versions
NO882233D0 (no
NO171065B (no
NO882233L (no
Inventor
Peter James Machin
Joseph Armstrong Martin
Gareth John Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO882233D0 publication Critical patent/NO882233D0/no
Publication of NO882233L publication Critical patent/NO882233L/no
Publication of NO171065B publication Critical patent/NO171065B/no
Publication of NO171065C publication Critical patent/NO171065C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO882233A 1987-05-22 1988-05-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater NO171065C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712115A GB8712115D0 (en) 1987-05-22 1987-05-22 Pyrimidine derivatives

Publications (4)

Publication Number Publication Date
NO882233D0 NO882233D0 (no) 1988-05-20
NO882233L NO882233L (no) 1988-11-23
NO171065B NO171065B (no) 1992-10-12
NO171065C true NO171065C (no) 1993-01-20

Family

ID=10617762

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882233A NO171065C (no) 1987-05-22 1988-05-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater

Country Status (19)

Country Link
EP (1) EP0292023A3 (is)
JP (1) JPS63303992A (is)
KR (1) KR880013927A (is)
CN (1) CN88103089A (is)
AU (1) AU602083B2 (is)
DK (1) DK165985C (is)
FI (1) FI882303A (is)
GB (1) GB8712115D0 (is)
HU (1) HU199868B (is)
IL (1) IL86394A0 (is)
IS (1) IS3344A7 (is)
MC (1) MC1934A1 (is)
MX (1) MX11493A (is)
NO (1) NO171065C (is)
NZ (1) NZ224638A (is)
PH (1) PH26909A (is)
PT (1) PT87550B (is)
YU (1) YU46860B (is)
ZA (1) ZA883447B (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340645C (en) * 1987-04-17 1999-07-13 Victor E. Marquez Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides
NZ232912A (en) * 1989-03-17 1992-06-25 Oncogen Ltd Lp Synergistic composition of nucleoside derivatives for inhibiting hiv
AU636678B2 (en) * 1989-11-06 1993-05-06 Nycomed Imaging As Nucleoside derivatives
AT400953B (de) * 1994-08-25 1996-05-28 Joern Saischek Pentofuranosid-derivate, deren herstellung und verwendung
EA008609B1 (ru) 1998-02-25 2007-06-29 Эмори Юниверсити 2'-фторнуклеозиды
PT1411954E (pt) 2000-10-18 2011-03-16 Pharmasset Inc Nucleosídeos modificados para o tratamento de infecções virais e proliferação celular anormal
WO2003000200A2 (en) 2001-06-22 2003-01-03 Pharmasset Ltd. β-2'-OR 3'-HALONUCLEOSIDES
DE602005015466D1 (de) 2004-08-23 2009-08-27 Hoffmann La Roche Antivirale 4'-azidonucleoside
US8895531B2 (en) 2006-03-23 2014-11-25 Rfs Pharma Llc 2′-fluoronucleoside phosphonates as antiviral agents
EP2361922B1 (en) 2006-10-10 2012-08-22 Janssen Products, L.P. Intermediate to HCV-Nucleoside Inhibitors

Also Published As

Publication number Publication date
PT87550A (pt) 1989-05-31
DK165985B (da) 1993-02-22
ZA883447B (en) 1988-11-22
IS3344A7 (is) 1988-11-23
MX11493A (es) 1993-09-01
PT87550B (pt) 1992-09-30
AU602083B2 (en) 1990-09-27
CN88103089A (zh) 1988-12-07
NO882233D0 (no) 1988-05-20
AU1631788A (en) 1988-11-24
DK227388A (da) 1988-11-23
JPS63303992A (ja) 1988-12-12
FI882303A0 (fi) 1988-05-17
KR880013927A (ko) 1988-12-22
EP0292023A2 (de) 1988-11-23
PH26909A (en) 1992-12-03
YU46860B (sh) 1994-06-24
NZ224638A (en) 1990-04-26
MC1934A1 (fr) 1989-05-19
EP0292023A3 (de) 1989-06-14
NO171065B (no) 1992-10-12
FI882303A (fi) 1988-11-23
DK165985C (da) 1993-11-08
DK227388D0 (da) 1988-04-26
NO882233L (no) 1988-11-23
GB8712115D0 (en) 1987-06-24
YU93288A (en) 1990-04-30
HU199868B (en) 1990-03-28
HUT47127A (en) 1989-01-30
IL86394A0 (en) 1988-11-15

Similar Documents

Publication Publication Date Title
NO170884C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO170483C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrahydronaftalin- og indanderivater
NO172540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrrolderivater
NO174101C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater
NO171506C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater
NO954489D0 (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive pyrimidinforbindelser
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO173545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
NO173442C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO169438C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser
NO171507C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater
NO172849C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO171065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO168037C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater.
NO169962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO172643C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.